Moroxydine is an antiviral agent originally developed for the treatment of influenza and other RNA and DNA viral infections by inhibiting viral polymerase enzymes. Analytical laboratories rely on high-quality… Read more
Moroxydine is an antiviral agent originally developed for the treatment of influenza and other RNA and DNA viral infections by inhibiting viral polymerase enzymes. Analytical laboratories rely on high-quality reference standards of the Moroxydine active pharmaceutical ingredient to support rigorous quality control and method validation protocols. This category provides access to essential materials for impurity profiling, including characterized pharmacopeial and non-pharmacopeial impurities that may arise during synthesis or storage. Furthermore, stable isotope labelled compounds, such as deuterated variants, are available to serve as internal standards for mass spectrometry-based assays, ensuring precise quantification and reliable analytical outcomes in pharmaceutical research. These reference materials are critical for the development and stability testing of antiviral therapeutics, allowing chemists to accurately monitor degradation products and verify the purity of drug substances throughout the analytical lifecycle.